Cargando…
Can HCV Core Ag Testing Replace the Routine Screening Assays in Patients on Hemodialysis?
Autores principales: | Einollahi, Behzad, Raeessi, Neda, Raeessi, Fereshteh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Kowsar
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4101326/ https://www.ncbi.nlm.nih.gov/pubmed/25067938 http://dx.doi.org/10.5812/hepatmon.16371 |
Ejemplares similares
-
Honey plus coffee versus systemic steroid in the treatment of persistent post-infectious cough: a randomised controlled trial
por: Raeessi, Mohammad Ali, et al.
Publicado: (2013) -
“Coffee plus Honey” versus “topical steroid” in the treatment of Chemotherapy-induced Oral Mucositis: a randomised controlled trial
por: Raeessi, Mohammad Ali, et al.
Publicado: (2014) -
Clinical utility of hepatitis C virus core antigen (HCVcAg) assay to identify active HCV infection in hemodialysis and renal transplant patients
por: Ponnuvel, Suresh, et al.
Publicado: (2021) -
Therapy for HBV Infection in Hemodialysis Patients: Is it Possible?
por: Einollahi, Behzad
Publicado: (2012) -
Prevalence and Sleep Related Disorders of Restless Leg Syndrome in Hemodialysis Patients
por: Chavoshi, Farzaneh, et al.
Publicado: (2015)